Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis

Clinical trial NCT00586651 · COMPLETED

Trial details

NCT number: NCT00586651
Sponsor: Cephalon
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Polycythemia Vera Essential Thrombocytosis

Start date: 2007-12-01
Primary completion: 2009-10-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.